+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

dPCR & qPCR Market by Product, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5367883
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The dPCR & qPCR Market grew from USD 8.05 billion in 2023 to USD 8.88 billion in 2024. It is expected to continue growing at a CAGR of 10.23%, reaching USD 15.94 billion by 2030.

Digital Polymerase Chain Reaction (dPCR) and quantitative Polymerase Chain Reaction (qPCR) are advanced molecular biology techniques used for nucleic acid quantification, offering unparalleled sensitivity and precision. These technologies are crucial in applications spanning clinical diagnostics, genomics, oncology, and personalized medicine. The market for dPCR and qPCR is largely driven by escalating demand for rapid diagnostic testing, increasing prevalence of infectious diseases, and the surge in genetic disorders. Enhanced healthcare infrastructure and supportive governmental policies further propel growth. Key market insights reveal a robust expansion trajectory owing to continuous technological advancements and burgeoning research activities. The pivot towards personalized medicine and genomic research underscores immense potential opportunities to be harnessed by stakeholders through strategic investments in R&D. However, the market faces challenges such as high costs associated with sophisticated dPCR and qPCR instruments, technical complexity, and the need for highly skilled personnel. Moreover, intellectual property issues and stringent regulatory requirements may impede market progress. To overcome these limitations, fostering collaborations with research institutions and focusing on innovations such as multiplexing capabilities and portable PCR devices can be beneficial. Innovations in point-of-care PCR technologies and integration of artificial intelligence for data analysis present new avenues for business expansion and operational efficiency. Investment in automated platforms that allow for higher throughput and reduced error margins could address market demands effectively. For sustained growth, organizations should prioritize expansion in emerging markets, where healthcare modernization and increased focus on preventative care offer untapped potential. Lastly, engaging in consumer education initiatives amplifies market penetration by elucidating the pivotal role of dPCR and qPCR in advanced diagnostic landscapes. By strategically aligning with these innovation and growth trajectories, businesses can optimize their market positioning within this dynamic and highly competitive sector.

Understanding Market Dynamics in the dPCR & qPCR Market

The dPCR & qPCR Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising prevalence of infectious diseases and genetic disorders
    • Increasing usage of dPCR and qPCR for efficient delivery of personalized medicine
    • Improving adoption in food testing procedures to ensure safety and consumption
  • Market Restraints
    • High cost associated with dPCR and qPCR
  • Market Opportunities
    • Technological advancements in PCR technologies
    • Growing funding for genomics research projects worldwide
  • Market Challenges
    • Technical limitations and data analysis complexities associated with dPCR and qPCR techniques

Exploring Porter’s Five Forces for the dPCR & qPCR Market

Porter’s Five Forces framework further strengthens the insights of the dPCR & qPCR Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the dPCR & qPCR Market

External macro-environmental factors deeply influence the performance of the dPCR & qPCR Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the dPCR & qPCR Market

The dPCR & qPCR Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the dPCR & qPCR Market

The dPCR & qPCR Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the dPCR & qPCR Market

The dPCR & qPCR Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the dPCR & qPCR Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Abbott Laboratories, accela s.r.o., Agilent Technologies, Inc., Analytik Jena GmbH, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., BioMed Central Ltd, BioMérieux S.A., Canopy Biosciences, LLC, Combinati Inc., Danaher Corporation, F. Hoffman-La Roche Ltd., GE Healthcare Inc., JN Medsys Pte. Ltd., Merck KGaA, PerkinElmer, Inc., Pfizer Inc., Promega Corporation, QIAGEN N.V. by Thermo Fisher Scientific, Inc., Roche Holding AG, Siemens Healthineers AG, Stilla Technologies SA, Takara Bio Inc., and Vela Diagnostics.

Market Segmentation & Coverage

This research report categorizes the dPCR & qPCR Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Instruments
    • Reagents & Consumables
    • Software & Services
  • Application
    • Clinical Application
      • Blood Screening
      • Oncology Testing
      • Pathogen Testing
    • Forensic Applications
    • Research Application
  • End-User
    • Academic Research & Institutes
    • Contract Research Organizations
    • Hospitals & Care Providers
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of infectious diseases and genetic disorders
5.1.1.2. Increasing usage of dPCR and qPCR for efficient delivery of personalized medicine
5.1.1.3. Improving adoption in food testing procedures to ensure safety and consumption
5.1.2. Restraints
5.1.2.1. High cost associated with dPCR and qPCR
5.1.3. Opportunities
5.1.3.1. Technological advancements in PCR technologies
5.1.3.2. Growing funding for genomics research projects worldwide
5.1.4. Challenges
5.1.4.1. Technical limitations and data analysis complexities associated with dPCR and qPCR techniques
5.2. Market Segmentation Analysis
5.2.1. Product: Expanding presence of sophisticated PCR instruments for rapid detection of genetic sequences
5.2.2. Application: Utilization of dPCR and qPCR in clinical applications for infection monitoring and detection
5.2.3. End-user: Rising focus of academic research and academic institutes toward PCR technologies
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. dPCR & qPCR Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents & Consumables
6.4. Software & Services
7. dPCR & qPCR Market, by Application
7.1. Introduction
7.2. Clinical Application
7.2.1. Blood Screening
7.2.2. Oncology Testing
7.2.3. Pathogen Testing
7.3. Forensic Applications
7.4. Research Application
8. dPCR & qPCR Market, by End-User
8.1. Introduction
8.2. Academic Research & Institutes
8.3. Contract Research Organizations
8.4. Hospitals & Care Providers
8.5. Pharmaceutical & Biotechnology Companies
9. Americas dPCR & qPCR Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific dPCR & qPCR Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa dPCR & qPCR Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. QIAGEN Expands Range of Digital PCR Kits and Services for the Biopharma Industry
12.3.2. Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
12.3.3. Thermo Fisher Scientific Launches New Digital PCR Automation Solution
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DPCR & QPCR MARKET RESEARCH PROCESS
FIGURE 2. DPCR & QPCR MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DPCR & QPCR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DPCR & QPCR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. DPCR & QPCR MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. DPCR & QPCR MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DPCR & QPCR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DPCR & QPCR MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DPCR & QPCR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DPCR & QPCR MARKET DYNAMICS
TABLE 7. GLOBAL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DPCR & QPCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DPCR & QPCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DPCR & QPCR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DPCR & QPCR MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DPCR & QPCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DPCR & QPCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DPCR & QPCR MARKET SIZE, BY FORENSIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DPCR & QPCR MARKET SIZE, BY RESEARCH APPLICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DPCR & QPCR MARKET SIZE, BY ACADEMIC RESEARCH & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DPCR & QPCR MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DPCR & QPCR MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DPCR & QPCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. CANADA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. CANADA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. CANADA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. CANADA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. MEXICO DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. MEXICO DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. MEXICO DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES DPCR & QPCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. CHINA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. CHINA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CHINA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CHINA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. INDIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. INDIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. INDIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. JAPAN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. JAPAN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. JAPAN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. JAPAN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. THAILAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. THAILAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. THAILAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. THAILAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA DPCR & QPCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. DENMARK DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. DENMARK DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. DENMARK DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. EGYPT DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. EGYPT DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. EGYPT DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. EGYPT DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FINLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. FINLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FINLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. FINLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. FRANCE DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. FRANCE DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. FRANCE DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. FRANCE DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. GERMANY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. GERMANY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. GERMANY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. GERMANY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. ITALY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. ITALY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ITALY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. NORWAY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. NORWAY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. NORWAY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. NORWAY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. POLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. POLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. POLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. POLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. QATAR DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. QATAR DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. QATAR DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. QATAR DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SPAIN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. SPAIN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SPAIN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SPAIN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. TURKEY DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. TURKEY DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. TURKEY DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. TURKEY DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM DPCR & QPCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. DPCR & QPCR MARKET SHARE, BY KEY PLAYER, 2023
TABLE 193. DPCR & QPCR MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the dPCR & qPCR Market, which are profiled in this report, include:
  • 10x Genomics, Inc.
  • Abbott Laboratories
  • accela s.r.o.
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioMed Central Ltd
  • BioMérieux S.A.
  • Canopy Biosciences, LLC
  • Combinati Inc.
  • Danaher Corporation
  • F. Hoffman-La Roche Ltd.
  • GE Healthcare Inc.
  • JN Medsys Pte. Ltd.
  • Merck KGaA
  • PerkinElmer, Inc.
  • Pfizer Inc.
  • Promega Corporation
  • QIAGEN N.V. by Thermo Fisher Scientific, Inc.
  • Roche Holding AG
  • Siemens Healthineers AG
  • Stilla Technologies SA
  • Takara Bio Inc.
  • Vela Diagnostics

Methodology

Loading
LOADING...

Table Information